B. Buhren

The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract

C. Matuschek, A. Erhardt, A. Scherer, 2011, European journal of medical research.

Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients

H. Bojar, G. Steinbach, A. Erhardt, 2011, European journal of medical research.

Evaluation of the tissue toxicity of antiseptics by the hen's egg test on the chorioallantoic membrane (HETCAM)

R. Mota, M. van Griensven, C. Matuschek, 2010, European journal of medical research.

Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysis.

H. Bojar, R. Sauer, C. Matuschek, 2013, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission

H. Bojar, R. Sauer, C. Matuschek, 2012, Strahlentherapie und Onkologie.

[Multimodal therapy in locally advanced gastric cancer].

C. Matuschek, A. Erhardt, A. Scherer, 2011, Deutsche medizinische Wochenschrift.

Trimodal therapy in squamous cell carcinoma of the esophagus

S. Baldus, W. Knoefel, C. Matuschek, 2011, European journal of medical research.

[Aesthetic Filler Injections and the Management of Side Effects].

P. Gerber, B. Buhren, M. Barsch, 2019, Laryngo- rhino- otologie.

[Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects].

B. Homey, P. Gerber, B. Buhren, 2010, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Ästhetische Behandlungen mit Fillern und das Management von Nebenwirkungen

B. Buhren, Autoren M. Barsch, P. A. Gerber, 2019, Laryngo-Rhino-Otologie.